Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for marginal zone B cell differentiation (biogroup)
Most Correlated Studies
- Erythroblasts splenic with hematopoietic cell-specific Rb and / or E2F8 knockout
- The Immunological Genome Project - Immune cell lineage differentiation and maturation
- The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
- Bone marrow, liver and spleen profiles from B6C3F1 mice treated with 2-butoxyethanol or hypoxia
- Stimulated B cells with induced IRF4 expression after IRF4 knockout
Most Relevant Literature
- Alpha-galactosylceramide-driven immunotherapy for allergy.
- The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the …
- Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the margi…
- Somatic hypermutation and B-cell lymphoma.
- Monocytoid/marginal zone B-cell differentiation in follicle centre cell lymphoma.
Most Relevant Clinical Trials
- 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma
- Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma
- Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
- Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
- Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Ly…
